CommentAntiretroviral roll-out: the problem of second-line therapy
References (11)
- et al.
Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon: open-label multicentre trial
Lancet
(2004) - et al.
The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings
Lancet
(2006) - et al.
The Sydney Declaration: a call to scale up research
Lancet
(2007) - et al.
Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes
JAMA
(2006) - et al.
The President's Emergency Plan for AIDS Relief in Africa: an evaluation of outcomes
Ann Intern Med
(2009)
There are more references available in the full text version of this article.
Cited by (18)
Comparative efficacy and safety of second-line antiretroviral therapy for treatment of HIV/AIDS: a systematic review and network meta-analysis
2017, The Lancet HIVCitation Excerpt :Scale-up of antiretroviral therapy (ART) has resulted in substantial reductions in HIV-related morbidity and mortality worldwide.1 With more people living with HIV receiving ART, and improved early detection of virological failure through better monitoring in resource-limited settings, a substantial number of patients might need to switch to second-line and subsequent regimens.2–5 Selection of optimal second-line ART has important clinical, public health, and programmatic implications.
After first-line ART: towards an evidence-based SECOND-LINE
2013, The LancetRitonavir-boosted lopinavir plus nucleoside or nucleotide reverse transcriptase inhibitors versus ritonavir-boosted lopinavir plus raltegravir for treatment of HIV-1 infection in adults with virological failure of a standard first-line ART regimen (SECOND-LINE): A randomised, open-label, non-inferiority study
2013, The LancetCitation Excerpt :High-quality evidence is needed to support treatment guidelines for people with HIV-1 who have virological failure with first-line combination antiretroviral therapy.1–6
Mobile phones to improve HIV treatment adherence
2010, The LancetART Regimen and Other Sociodemographics Do Not Affect Cytokine Expression in HIV Patients in Ghana
2019, Canadian Journal of Infectious Diseases and Medical Microbiology
Copyright © 2009 Elsevier Ltd. All rights reserved.